Emd Serono Research & Development Institute, Inc.
Clinical trials sponsored by Emd Serono Research & Development Institute, Inc., explained in plain language.
-
New pill aims to tame painful lupus skin flares in major trial
Disease control Not yet recruitingThis study is testing whether a new pill called enpatoran can safely reduce the severity of skin rashes caused by lupus. About 202 adults with active lupus skin symptoms, with or without other body-wide lupus disease, will take either the study pill or a placebo for 24 weeks whil…
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New lupus skin rash pill enters final testing phase
Disease control Not yet recruitingThis study aims to see if a new pill called enpatoran can safely reduce skin rashes and symptoms in people with lupus. About 202 participants with active lupus skin disease will take either the drug or a placebo pill for 24 weeks while continuing their standard lupus medications.…
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New pill aims to tame painful lupus skin flares
Disease control Not yet recruitingThis study is testing whether a pill called enpatoran can safely reduce active skin rashes in people with lupus. About 202 participants with moderate-to-severe lupus skin symptoms will take either enpatoran or a placebo pill for 24 weeks, while continuing their standard lupus med…
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC